Safety and Cinical Outcomes of the 1064 nm Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) Laser Combined with Topical Antifungal Agents for Onychomycosis in Patients with Diabetes Mellitus

키워드

참고문헌 (10)

1. Scher RK, "The epidemiology, etiology, and pathophysiology of onychomycosis", Semin Cutan Med Surg, 32, pp.S2~S4 (2013)
2. Gupta AK, "Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicenter survey", Br J Dermatol, 139, pp.665~671 (1998)
3. Robbins JM, "Treatment of onychomycosis in the diabetic patient population", J Diabetes Complications, 17, pp.98~104 (2003)
4. 김현주, "Clinical Factors Influencing Outcomes of 1064 nm Neodymium-Doped Yttrium Aluminum Garnet (Nd:YAG) Laser Treatment for Onychomycosis", Annals of Dermatology, 30(4), pp.493~495 (2018), 대한피부과학회
5. Horine C, "Evaluation of a short pulse Nd:YAG laser procedure for infected nails - A retrospective international multicenter study of 262 patients" (2014), Cynosure, Inc
6. Carney C, "A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index", Arch Dermatol, 147, pp.1277~1282 (2011)
7. Nijenhuis-Rosien L, "Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1)", J Eur Acad Dermatol Venereol, 33, pp.2143~2150 (2019)
8. Karsai S, "Treating onychomycosis with the shortpulsed 1064-nm-Nd:YAG laser: results of a prospective randomized controlled trial", J Eur Acad Dermatol Venereol, 31, pp.175~180 (2017)
9. Eckhard M, "Fungal foot infections in patients with diabetes mellitus -results of two independent investigations", Mycoses, 50(Supple 2), pp.14~19 (2007)
10. Lipner SR, "Onychomycosis: Treatment and prevention of recurrence", J Am Acad Dermatol, 80, pp.853~867 (2019)

관련 논문AI추천